Primary cutaneous CD4‐positive small/medium T‐cell lymphoproliferative disorder: The first‐reported Latin‐American case with response to doxycycline

Primary cutaneous CD4+ small/medium T‐cell lymphoproliferative disorder is a provisional entity according to the last WHO‐EORTC classification. The treatment of choice has not yet been defined. Local therapies have been used with variable response. Doxycycline as a main treatment option is a potenti...

Descripción completa

Detalles Bibliográficos
Autores principales: Escanilla, Claudio, Guavita Falla, Piedad Marcela, Cevallos, Carolina, Ávalos Jobet, Nicolás, Bobadilla Bruneau, Francisco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6935602/
https://www.ncbi.nlm.nih.gov/pubmed/31893069
http://dx.doi.org/10.1002/ccr3.2454
_version_ 1783483600493084672
author Escanilla, Claudio
Guavita Falla, Piedad Marcela
Cevallos, Carolina
Ávalos Jobet, Nicolás
Bobadilla Bruneau, Francisco
author_facet Escanilla, Claudio
Guavita Falla, Piedad Marcela
Cevallos, Carolina
Ávalos Jobet, Nicolás
Bobadilla Bruneau, Francisco
author_sort Escanilla, Claudio
collection PubMed
description Primary cutaneous CD4+ small/medium T‐cell lymphoproliferative disorder is a provisional entity according to the last WHO‐EORTC classification. The treatment of choice has not yet been defined. Local therapies have been used with variable response. Doxycycline as a main treatment option is a potential low‐cost and effective alternative for this disorder.
format Online
Article
Text
id pubmed-6935602
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-69356022019-12-31 Primary cutaneous CD4‐positive small/medium T‐cell lymphoproliferative disorder: The first‐reported Latin‐American case with response to doxycycline Escanilla, Claudio Guavita Falla, Piedad Marcela Cevallos, Carolina Ávalos Jobet, Nicolás Bobadilla Bruneau, Francisco Clin Case Rep Case Reports Primary cutaneous CD4+ small/medium T‐cell lymphoproliferative disorder is a provisional entity according to the last WHO‐EORTC classification. The treatment of choice has not yet been defined. Local therapies have been used with variable response. Doxycycline as a main treatment option is a potential low‐cost and effective alternative for this disorder. John Wiley and Sons Inc. 2019-10-29 /pmc/articles/PMC6935602/ /pubmed/31893069 http://dx.doi.org/10.1002/ccr3.2454 Text en © 2019 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Reports
Escanilla, Claudio
Guavita Falla, Piedad Marcela
Cevallos, Carolina
Ávalos Jobet, Nicolás
Bobadilla Bruneau, Francisco
Primary cutaneous CD4‐positive small/medium T‐cell lymphoproliferative disorder: The first‐reported Latin‐American case with response to doxycycline
title Primary cutaneous CD4‐positive small/medium T‐cell lymphoproliferative disorder: The first‐reported Latin‐American case with response to doxycycline
title_full Primary cutaneous CD4‐positive small/medium T‐cell lymphoproliferative disorder: The first‐reported Latin‐American case with response to doxycycline
title_fullStr Primary cutaneous CD4‐positive small/medium T‐cell lymphoproliferative disorder: The first‐reported Latin‐American case with response to doxycycline
title_full_unstemmed Primary cutaneous CD4‐positive small/medium T‐cell lymphoproliferative disorder: The first‐reported Latin‐American case with response to doxycycline
title_short Primary cutaneous CD4‐positive small/medium T‐cell lymphoproliferative disorder: The first‐reported Latin‐American case with response to doxycycline
title_sort primary cutaneous cd4‐positive small/medium t‐cell lymphoproliferative disorder: the first‐reported latin‐american case with response to doxycycline
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6935602/
https://www.ncbi.nlm.nih.gov/pubmed/31893069
http://dx.doi.org/10.1002/ccr3.2454
work_keys_str_mv AT escanillaclaudio primarycutaneouscd4positivesmallmediumtcelllymphoproliferativedisorderthefirstreportedlatinamericancasewithresponsetodoxycycline
AT guavitafallapiedadmarcela primarycutaneouscd4positivesmallmediumtcelllymphoproliferativedisorderthefirstreportedlatinamericancasewithresponsetodoxycycline
AT cevalloscarolina primarycutaneouscd4positivesmallmediumtcelllymphoproliferativedisorderthefirstreportedlatinamericancasewithresponsetodoxycycline
AT avalosjobetnicolas primarycutaneouscd4positivesmallmediumtcelllymphoproliferativedisorderthefirstreportedlatinamericancasewithresponsetodoxycycline
AT bobadillabruneaufrancisco primarycutaneouscd4positivesmallmediumtcelllymphoproliferativedisorderthefirstreportedlatinamericancasewithresponsetodoxycycline

Ejemplares similares